Ambrx Provides Safety and Efficacy Data from Ongoing Phase 12 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress
| AMAMDelisted Stock | USD 15.73 0.71 4.73% |
About 55% of Ambrx Biopharma's investors are presently thinking to get in. The analysis of current outlook of investing in Ambrx Biopharma American suggests that some traders are interested regarding Ambrx Biopharma's prospects. Ambrx Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Ambrx Biopharma American. Many technical investors use Ambrx Biopharma American stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Ambrx |
Newly published abstract regarding dose escalation patients provides key updates including 50 percent PSA reduction observed across putative therapeutic dose levels 2.0 mgkg 3 of 3 in Cohort 6 , 2 of 3 in
Read at benzinga.com
 |
Ambrx Biopharma Fundamental Analysis
We analyze Ambrx Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ambrx Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ambrx Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Ambrx Biopharma is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Ambrx Biopharma American Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ambrx Biopharma stock to make a market-neutral strategy. Peer analysis of Ambrx Biopharma could also be used in its relative valuation, which is a method of valuing Ambrx Biopharma by comparing valuation metrics with similar companies.
Peers
Ambrx Biopharma Related Equities
| XFOR | X4 Pharmaceuticals | 11.43 | ||||
| IMMX | Immix Biopharma | 7.11 | ||||
| HEPA | Hepion Pharmaceuticals | 4.69 | ||||
| ELEV | Elevation Oncology | 3.23 | ||||
| ENVB | Enveric Biosciences | 3.13 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| DAWN | Day One | 1.53 | ||||
| ABOS | Acumen Pharmaceuticals | 0.44 | ||||
| INZY | Inozyme Pharma | 0.37 | ||||
| OCEA | Ocean Biomedical | 1.41 | ||||
| SONN | Sonnet Biotherapeutics | 2.28 | ||||
| CNSP | Cns Pharmaceuticals | 8.33 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |